A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 594-600

  Fang, Carolyn Y ^a   Cherry, Carol ^a   Devarajan, Karthik ^a   Li, Tianyu ^a   Malick, John ^a   Daly, Mary B ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Ovarian cancer; Prophylactic surgery; Quality of life; Screening

Indexed keywords

ADULT; ARTICLE; BODY IMAGE; CANCER PAIN; CANCER RISK; CANCER SCREENING; DEPRESSION; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; HOT FLUSH; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK REDUCTION; SALPINGOOOPHORECTOMY; SATISFACTION; SEXUAL BEHAVIOR; SEXUALITY; SOCIAL STATUS; VAGINAL DISCOMFORT; VAGINAL DRYNESS;

ADULT; BODY IMAGE; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SEXUAL BEHAVIOR;

EID: 60449101484     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.11.039     Document Type: Article

References (45)

1. Antoniou A., Pharoah P.D., Narod S., Risch H.A., Eyfjord J.E., Hopper J.L., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72 (2003) 1117-1130
2. NCCN genetic/familial high-risk assessment: breast and ovarian, v.1.2007, available @ http://www.nccn.org/.
3. Gaarenstroom K.N., van der Hiel B., Tollenaar R.A., Vink G.R., Jansen F.W., van Asperen C.J., et al. Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int. J. Gynecol. Cancer 16 Suppl 1 (2006) 54-59
4. Hogg R., and Friedlander M. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J. Clin. Oncol. 22 (2004) 1315-1327
5. Stirling D., Evans D.G., Pichert G., Shenton A., Kirk E.N., Rimmer S., et al. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics system. J. Clin. Oncol. 23 (2005) 5588-5596
6. Finch A., Beiner M., Lubinski J., Lynch H.T., Moller P., Rosen B., et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296 (2006) 185-192
7. Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., Van't Veer L., Garber J.E., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 346 (2002) 1616-1622
8. Rosen B., Kwon J., Fung Kee Fung M., Gagliardi A., and Chambers A. Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol. Oncol. 93 (2004) 280-286
9. Kauff N.D., Domchek S.M., Friebel T.M., Robson M.E., Lee J., Garber J.E., et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J. Clin. Oncol. 26 (2008) 1331-1337
10. Guillem J.G., Wood W.C., Moley J.F., Berchuck A., Karlan B.Y., Mutch D.G., et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J. Clin. Oncol. 24 (2006) 4642-4660
11. Meiser B., Tiller K., Gleeson M.A., Andrews L., Robertson G., and Tucker K. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psycho-Oncology 9 (2000) 496-503
12. Hallowell N., Mackay J., Richards M., Gore M., and Jacobs I. High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive study. Genet. Test 8 (2004) 148-156
13. Kauff N.D., Hurley K.E., Hensley M.L., Robson M.E., Lev G., Goldfrank D., et al. Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up. Cancer 104 (2005) 314-320
14. Hensley M.L., Robson M.E., Kauff N.D., Korytowsky B., Castiel M., Ostroff J., et al. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Gynecol. Oncol. 89 (2003) 440-446
15. Elit L., Esplen M.J., Butler K., and Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam. Cancer 1 (2001) 149-156
16. Madalinska J.B., Hollenstein J., Bleiker E., van Beurden M., Valdimarsdottir H.B., Massuger L.F., et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J. Clin. Oncol. 23 (2005) 6890-6898
17. Robson M., Hensley M., Barakat R., Brown C., Chi D., Poynor E., et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol. Oncol. 89 (2003) 281-287
18. Bresser P.J.C., Seynaeve C., Van Gool A.R., Niermeijer M.F., Duivenvoorden H.J., van Dooren S., et al. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur. J. Cancer 43 (2007) 95-103
19. Tiller K., Meiser B., Butow P., Clifton M., Thewes B., Friedlander M., et al. Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. Gynecol. Oncol. 86 (2002) 212-219
20. Ware J.E. SF-36 Health Survey Manual and Interpretation Guide (1993), The Health Institute, Boston
21. Ware J.E., and Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36). Med. Care 30 (1992) 473-483
22. Ganz P.A., Day R., Ware Jr. J.E., Redmond C., and Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J. Natl. Cancer Inst. 87 (1995) 1372-1382
23. Day R., Ganz P.A., Costantino J.P., Cronin W.M., Wickerham D.L., and Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Clin. Oncol. 17 (1999) 2659
24. Ganz P.A., Rowland J.H., Desmond K., Meyerowitz B.E., and Wyatt G.E. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J. Clin. Oncol. 16 (1998) 501-514
25. Mortimer J.E., Boucher L., Baty J., Knapp D.L., Ryan E., and Rowland J.H. Effect of tamoxifen on sexual functioning in patients with breast cancer. J. Clin. Oncol. 17 (1999) 1488-1492
26. Thirlaway K., Fallowfield L., and Cuzick J. The Sexual Activity Questionnaire: a measure of women's sexual functioning. Qual. Life Res. 5 (1996) 81-90
27. Berscheid E., Walster E., and Bohrnstedt G. The happy American body: a survey report. Psychol. Today 7 (1973) 119-131
28. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
29. Tiffen J., Sharp L., and O'Toole C. Depressive symptoms prescreening and postscreening among returning participants in an ovarian cancer early detection program. Cancer Nurs. 28 (2005) 325-330
30. Vadaparampil S.T., Ropka M., and Stefanek M.E. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers. Fam. Cancer 4 (2005) 195-206
31. Finlayson T.L., Moyer C.A., and Sonnad S.S. Assessing symptoms, disease severity, and quality of life in the clinical context: a theoretical framework. Am. J. Manag. Care 10 (2004) 336-344
32. Arndt V., Stegmaier C., Ziegler H., and Brenner H. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer 107 (2006) 2496-2503
33. Sprangers M.A.G., and Schwartz C.E. The challenge of response shift for quality-of-life-based clinical oncology research. Ann. Oncol. 10 (1999) 747-749
34. Knobf M.T. Carrying on: the experience of premature menopause in women with early stage breast cancer. Nurs. Res. 51 (2002) 9-17
35. Knobf M.T. "Coming to grips" with chemotherapy-induced premature menopause. Health Care Women Int. 29 (2008) 384-399
36. Graziottin A., and Basson R. Sexual dysfunction in women with premature menopause. Menopause 11 (2004) 766-777
37. Ganz P.A., Guadagnoli E., Landrum M.B., Lash T.L., Rakowski W., and Silliman R.A. Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J. Clin. Oncol. 21 (2003) 4027-4033
38. Hopwood P., Haviland J., Mills J., Sumo G., and JMB. The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 16 (2007) 241-251
39. Janz N.K., Mujahid M., Chung L.K., Lantz P.M., Hawley S.T., Morrow M., et al. Symptom experience and quality of life of women following breast cancer treatment. J. Women's Health (15409996) 16 (2007) 1348-1361
40. Ganz P.A., Greendale G.A., Petersen L., Kahn B., and Bower J.E. Breast cancer in younger women: reproductive and late health effects of treatment. J. Clin. Oncol. 21 (2003) 4184-4193
41. Mor V., Malin M., and Allen S. Age differences in the psychosocial problems encountered by breast cancer patients. J. Natl. Cancer Inst. Monogr. (1994) 191-197
42. Bresser P.J.C., Van Gool A.R., Seynaeve C., Duivenvoorden H.J., Niermeijer M.F., van Geel A.N., et al. Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?. Ann. Oncol. 18 (2007) 1641-1645
43. Garry R., Fountain J., Brown J., Manca A., Mason S., Sculpher M., et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol. Assess. 8 (2004) 1-154
44. Kluivers K.B., Hendriks J.C., Mol B.W., Bongers M.Y., Bremer G.L., de Vet H.C., et al. Quality of life and surgical outcome after total laparoscopic hysterectomy versus total abdominal hysterectomy for benign disease: a randomized, controlled trial. J. Minim. Invasive. Gynecol. 14 (2007) 145-152
45. Kluivers K.B., Johnson N.P., Chien P., Vierhout M.E., Bongers M., and Mol B.W. Comparison of laparoscopic and abdominal hysterectomy in terms of quality of life: a systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 136 (2008) 3-8